Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors

Fawen Chen1 Department of Clinical Laboratory, Fujian Provincial Hospital South Branch;2 Department of Blood TransfusionCorrespondence[email protected]

Jing Shen3 Department of Clinical Laboratory, Fujian Provincial Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, People’s Republic of China

Jianwei Wang1 Department of Clinical Laboratory, Fujian Provincial Hospital South Branch

Pengwei Cai1 Department of Clinical Laboratory, Fujian Provincial Hospital South Branch

Yi Huang3 Department of Clinical Laboratory, Fujian Provincial Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, People’s Republic of China

Pages 1313-1318 | Published online: 22 May 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
PubMed Web of Science ®Google Scholar
OberaignerWMinicozziPBielska-LasotaMEurocare Working GroupSurvival for ovarian cancer in Europe: the across-country variation did not shrink in the past decadeActa Oncol201251444145322313338
PubMed Web of Science ®Google Scholar
SiegelRNaishadhamDJemalACancer statistics, 2013CA Cancer J Clin2013631113023335087
PubMed Web of Science ®Google Scholar
PatsnerBYimGWPredictive value of preoperative serum CA-125 levels in patients with uterine cancer: the Asian experience 2000 to 2012Obstet Gynecol Sci201356528128824328017
PubMedGoogle Scholar
NicklinJJandaMGebskiVLACE Trial InvestigatorsThe utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancerInt J Cancer2012131488589021918977
PubMed Web of Science ®Google Scholar
DistlerMPilarskyEKerstingSGrützmannRPreoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – a retrospective tumor marker prognostic studyInt J Surg201311101067107224161419
PubMed Web of Science ®Google Scholar
MooreRGBrownAKMilleMCUtility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterusGynecol Oncol2008110219620118495222
PubMed Web of Science ®Google Scholar
MooreRGBrownAKMillerMCThe use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic massGynecol Oncol2008108240240818061248
PubMed Web of Science ®Google Scholar
ShenJHuangYChenWThe diagnostic value of serum HE4 and Ca-125 and ROMA index in pelvic malignant tumorJ Fujian Med Univ201448395399
Google Scholar
KarlsenMASandhuNHegdallCEvaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic massGynecol Oncol2012127237938322835718
PubMed Web of Science ®Google Scholar
AroraVQuinnMAEndometrial cancerBest Pract Res Clin Obstet Gynaecol201226331132422277287
PubMed Web of Science ®Google Scholar
LamerzRRole of tumour markers, cytogeneticsAnn Oncol199910Suppl 414514910436809
PubMed Web of Science ®Google Scholar
FiorettiPGadducciAFerdeghiniMThe concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patientsGynecol Oncol19924421551601544592
PubMed Web of Science ®Google Scholar
ZhangZLYuYXuFCombining multiple serum tumor markers improves detection of stage I epithelial ovarian cancerGynecol Oncol2007107352653117920110
PubMed Web of Science ®Google Scholar
SkatesSJHorickNYuYPreoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA125, CA15-3, CA72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributionsJ Clin Oncol200422204059406615381683
PubMed Web of Science ®Google Scholar
HellstromIRaycraftJHayden-LedbetterMThe HE4 (WFDC2) protein is a biomarker for ovarian carcinomaCancer Res200363133695337012839961
PubMed Web of Science ®Google Scholar
ZanottiLBignottiECalzaSHuman epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcomeClin Chem Lab Med201250122189219823096757
PubMed Web of Science ®Google Scholar
BignottiERagnoliMZanottiLDiagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patientsBr J Cancer201110491418142521468050
PubMed Web of Science ®Google Scholar
MalkasianGDJrKnappRCLavinPTPreoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant diseaseAm J Obstet Gynecol198815923413462457318
PubMed Web of Science ®Google Scholar
ZurawskiVRJrKnappRCEinhornNAn initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaGynecol Oncol19883017142452773
PubMed Web of Science ®Google Scholar
EinhornNSjovallKKnappRCProspective evaluation of serum CA 125 levels for early detection of ovarian cancerObstet Gynecol199280114181603484
PubMed Web of Science ®Google Scholar
ScaràSBottoniPScatenaRCA19-9: biochemical and clinical aspectsAdv Exp Med Biol201586724726026530370
PubMed Web of Science ®Google Scholar
KimJYKimNKSohnSKPrognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levelsAnn Surg Oncol200916102771277819657698
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical analysis of four serum tumor markers in 458 patients with ovarian tumors: diagnostic value of the combined use of HE4, CA125, CA19-9, and CEA in ovarian tumors

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date